MBX Biosciences (MBX) Net Equity Issued and Repurchased (2023)

MBX Biosciences (MBX) reported Net Equity Issued and Repurchased of $68.5 million for Q4 2023.

MBX Biosciences (MBX) Net Equity Issued and Repurchased (2023) Analysis & Trends

MBX Biosciences (MBX) has 1 years of Net Equity Issued and Repurchased data on file, last reported at $68.5 million in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	163.10 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	141.90 Mn
10	MBX Biosciences	2.96 Bn	2.96 Bn	-	-

Download Data

Date	Value
Dec 31, 2023	68.51 Mn
Dec 31, 2023	68.51 Mn